Epidemiological studies suggest UVA play a signiˆcant role in the induction of skin cancers. Nucleic acids and proteins have extremely weak extinctions in UVA and visible light regions. The absorption of UVA energy is dependent on endogenous or exogenous sensitizers, and the photogenotoxicity of UVA is derived from the excited sensitizers. Photosensitive medicines, carcinogens and endogenous compounds can participate in UVA-induced photogenotoxicity and photomutagenicity. Irradiated medicines reported to be involved in photosensitization and phototoxicity such as antipsychotics, antihistamine agents, non-steroidal anti-in‰ammatory drugs, antihypertensive drugs, anti-diabetic agents, antibiotics, antifungal drugs and antibacterial agents. As an alternate pathway for activation, several carcinogens can be converted with UVA to reactive intermediates that bind DNA in the absence of the activation enzymes. Several endogenous compounds have also been reported to act photosensitizers. Photogenotoxicity and photomutagenicity are unwanted side-eŠects related to the UV-mediated activation of chemicals. In considering risks and beneˆts, the interrelationship between light, chemicals and human health remain an important topic of research.
Introduction
Solar radiation has radiant energy comprising a broad spectrum including ultraviolet (UV) C (100-280 nm), UVB (280-315 nm) and UVA (315-400 nm) regions ( Fig. 1) (1, 2) . Since sunlight with wavelength 300 nm or shorter is eliminated during passing through the atmosphere including the ozone layer, UVC and part of UVB is absent in natural sunlight at the surface of the earth. Part of UVB, UVA, visible and infrared radiation can reach the surface of the earth. The production of photoproducts in DNA by solar UV is markedly wavelength-dependent (2) (3) (4) . DNA can absorb UVB light and a multitude of photoproducts can be formed. The absorption of photon energy may be achieved either directly by the DNA molecules (for wavelengths º320 nm), or by endogenous or exogenous sensitizers with subsequent energy or electron transfer to DNA. However, nucleic acids and proteins have extremely weak extinctions in UVA and visible light regions. The absorption of UVA energy is dependent on endogenous or exogenous sensitizers, and the phototoxicity of UVA is derived from the excited sensitizers. Photosensitising chemicals usually have a low molecular weight, are often planar conˆgurations with polycyclic structure, and absorb UV and/or visible light (Table 1) (3, 4) . Absorbed photons provide energy to chemicals to facilitate transition from the ground state to the excited state. Type I and Type II photoreactions of excited molecules with DNA have been investigated as part of the photoreaction scheme (1) (2) (3) (4) . With Type I photoreactions, excited molecules or generated active intermediates react directly with DNA, or the photoenergy is transferred to DNA from excited molecules and the excited DNA molecules subsequently react with oxygen or other molecules which leads to damaged DNA. With Type II photoreactions, photo-excited molecules react with molecular oxygen to produce active oxygen species that engage in a photochemical attack upon DNA. Medicines, carcinogens and endogenous compounds that can participate in UVA-induced photogenotoxicity and photogenotoxicity will be discussed in this manuscript.
Photogenotoxicity and Photomutagenicity of Drugs
The photogenotoxicity of medicines resulting from sunlight irradiation has been investigated (3) (4) (5) . Irradiated medicines reported to be involved in photosensitization and phototoxicity such as antipsychotics, antihistamine agents, non-steroidal anti-in‰ammatory drugs, antihypertensive drugs, anti-diabetic agents, antibiotics, antifungal drugs and antibacterial agents are shown in Table 1 .
Furocoumarins, such as psoralens and angelicins, are 
106 Sakae Arimoto-Kobayashi well-known photoactive reagents (3) (4) (5) (6) . A combination of psoralen with UVA radiation (PUVA) was used in the treatment of psoriasis (3) (4) (5) (6) . PUVA therapy is carcinogenic to humans causing cutaneous squamous cell carcinoma (SCC) (7) . The photoactivation of psoralens in skin cells leads to DNA photoadduct formation and subsequent mutations may lead to an increased incidence of SCC. In vivo application of 8-methoxypsora- Photomutagenicity of Chemicals len to the back of hairless mice with irradiation of simulated sunlight increased frequency of micronucleated cells at the irradiated skin (8) . Furocoumarins are frequently used as a positive control in the examination of photogenotoxicity of chemicals and in the development of new assay systems for the detection of photomutagenicity (7-13).
Photosensitizing chlorpromazine, an anti-psychotic, under UVA irradiation induced DNA photoadducts (14) and apoptosis in keratinocytes (9, 15) . The photomutagenicity of chlorpromazine resulting from irradiation with near UV light (NUV, 300-400 nm) has been conrmed in S. typhimurium, E. coli and CHO cells (11, 12) .
The photoactivation of antibacterial ‰uoroquino-lones, such as Lome‰oxacin, Cipro‰oxacin, Ru‰oxacin, Spar‰oxacin and Fleroxacin, has been reported as a side-eŠect. The photo-induced genotoxicity of ‰uoro-quinolones was also studied in tests concerning gene mutation, chromosomal aberration, gene conversion and DNA breakage (9, (16) (17) (18) (19) (20) . In vivo photochemical micronucleus induction and photocarcinogenicity of Lome‰oxacin were reported (21) (22) (23) . The mechanisms involved in the photoreaction of ‰uoroquinolones were investigated and an association between the cationic ring of ‰uoroquinolones and the phosphate moieties of DNA has been suggested, in addition to the involvement of reactive oxygen species (ROS) (17, 20) . With respect to the antifungal and antibiotic group, the photosensitivity of sulfamethoxazole, tetracycline and griseofulvin has also been investigated (24) (25) (26) (27) . Natural sunlight in addition to UV light enhanced the toxicity of sulfonamides (24) . Thiabendazole, a post-harvest fungicide used on citrus fruit, was also photomutagenic in bacteria strains subjected to UVA irradiation (28) .
The photodegradation and phototoxicity of diuretic hydrochlorothiazide (29) and the antidiabetic drug chlorpropamide (30) have also been reported. The topical use of nonsteroidal anti-in‰ammatory drugs (NSAIDs) can induce photosensitivity in the form of phototoxic and photoallergic reactions (3, 31) . In the presence of ketoprofen, a NSAID, irradiated DNA undergoes single strand breaks involving hydroxyl radicals. The simultaneous activity of Type I and Type II photoprocesses, i.e., radical processes leading to DNA cleavage and energy transfer between ketoprofen and pyrimidines, was suggested (31). The chemotherapeutic and chemopreventive agent tamoxifen was found to be photomutagenic in S. typhimurium TA102 and DNAtamoxifen covalent adducts were identiˆed (32).
Photoactivation of Carcinogens
Carcinogenic mutagens that have been subjected to photoactivation are shown in Table 1 . Polycyclic aromatic hydrocarbons (PAHs), such as benzo(a)pyrene (B(a)P) and 7,12-dimetylbenxo(a)anthracene (DMBA), have been identiˆed as a possible human carcinogens (33, 34) . The bioactivation of B(a)P is mediated by CYP enzymes that form the toxic intermediate benzo(a)pyrene-7,8-dihydrodiol-9,10-epoxide (33, 35) . As an alternate pathway for activation, B(a)P can be converted with UVA to reactive intermediates that bind DNA in the absence of the activation enzymes (36) (37) (38) . Exposure of S. typhimurium TA102 to UVA in the presence of PAH, including B(a)P, can lead to photomutagenic responses (36, 37) . The production of reactive oxygen species (ROS) was also assessed during the photoactivation of B(a)P (38) . Evaluating in vivo photogenotoxicity, B(a)P was applied to the dorsal skin of hairless mice under the simulated sunlight. A signiˆcant increase of the frequency of micronucleated cells was observed at the basal epidermal cells in the treated skin (8) . Photo-irradiation of DMBA in the presence of DNA produced multiple DNA adducts, which might be the source of photomutagenicity of DMBA (39) . Amino or nitro derivatives of PAHs, such as 1-aminopyrene, 6-nitrobenzo(a)pyrene and 2-nitro‰uorene, have been shown to be activated by UVA to form reactive intermediates that bind covalently to DNA and RNA (40) (41) (42) .
N-Nitroso compounds occur in the environment and can induce cancer (43, 44) . It was thought that nitrosamine itself was an inert solvent, and that the metabolites of nitrosamine were responsible for the toxic eŠects (43, 44) . With simultaneous irradiation of UVA, photomutagenic eŠects of N-dialkylnitrosamines were observed in Ames bacteria (S. typhimurium TA1535) in the absence of metabolic activation (45, 46) . The Ndialkylnitrosamines produced strand breaks in treated DNA in the presence of UVA. UVA-mediated mutations with N-nitrosamine decreased with the addition of either NO or OH radical scavenger. The action spectra of N-nitrosamine phototoxicity were investigated. The plots of mutation frequency and NO formation aligned with the absorption curve of N-nitrosamine, indicating that nitrosamine acts as a sensitizer of UVA. The proposed hypothesis involves the absorption of UVA photons by the N-nitroso moiety of N-dialkylnitrosamines, UVA-photolysis of N-dialkylnitrosamines to release nitric oxide, and subsequent production of alkyl radical cations and active oxygen species which cause DNA strand breaks, oxidative and alkylative DNA damage, and mutations (45, 46) .
Photoactivation of Endogenous Compound
Several endogenous compounds have been reported to act photosensitizers (Table 1) .
Upon exposure to UVA, ribo‰avin can damage DNA and RNA bases (47, 48) . Photosensitized formation of 8-oxo-7,8-dihydro-2?-deoxyguanosine (8-oxodG) in DNA by ribo‰avin has been shown (47, 48) . The induction of mutations in murine cells was observed following treatment with ribo‰avin and visible light (49) .
N-Nitrosoproline (NPRO) is known to be endogenously formed from proline and nitrite, and has been reported to be nonmutagenic and noncarcinogenic (50) . However, direct mutagenic eŠects of NPRO with UVA or natural sunlight towards S. typhimurium have been reported (51) . The formation of 8-oxodG, a mutagenic lesion, was observed in calf thymus DNA treated with NPRO and UVA. An analysis using scavengers suggested that both reactive oxygen species and NO radicals mediate the strand breaks occurring in DNA on treatment with NPRO and UVA. A solution containing NPRO and dG was irradiated with UVA and the resulting photoproducts were analyzed by HPLC (52, 53) . Three known modiˆed guanine nucleosides, 2?-deoxyxanthosine, 8-oxodG and 2?-deoxyoxanosine, and two new products, (R)-and (S)-8-(2-pyrrolidyl)-2?-deoxyguanosine were isolated and identiˆed from the irradiated mixture. Theˆnding that the plots of photoproduct formation and NO release match the absorption curve of NPRO, being highest at 340 nm, suggests that the rate limiting step of photoproduct formation is the photo-cleavage of excited NPRO. Thus, a possible mechanism of photoproduct formation may involve release of NO from NPRO which then results in formation of an active intermediate (52, 53) . The co-mutagenic and co-toxic actions of NPRO and UVA suggest possible mechanisms involving increased carcinogenic risk from UVA irradiation.
Conclusion
The role of UVA in the phototoxicity and photogenotoxicity of carcinogens and chemicals has been investigated by many research groups. Interaction of light with these chemicals leads to photosensitive responses in vitro and in vivo. With taking into account the eŠects of the photochemical reaction of chemicals to DNA, it is possible to make better estimation of the activity and toxicity of the chemicals in the environment. Photogenotoxicity and photomutagenicity are unwanted side-eŠects related to the UV-mediated activation of drugs and medicines, and furthering our knowledge of phototoxicity should assist in eŠorts to estimate the human safety risks involved. In considering risks and beneˆts, the interrelationship between light, chemicals and human health remain an important topic of research. 
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